Exploratory insights from the immuno-oncology hollow fiber assay: A pilot approach bridging In Vitro and In Vivo models

To facilitate the translation of immunotherapies from bench to bedside, predictive preclinical models are essential. We developed the in vivo immuno-oncology Hollow Fiber Assay (HFA) to bridge the gap between simpler cell-based in vitro assays and more complex mouse models for immuno-oncology drug e...

Full description

Bibliographic Details

Published in:	SLAS Technology
Main Authors:	Tove Selvin, Malin Berglund, Anders Åkerström, Marco Zia, Jakob Rudfeldt, Malin Jarvius, Rolf Larsson, Claes R Andersson, Mårten Fryknäs
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Subjects:	Immuno-oncology Preclinical modeling Mouse models Hollow fibers
Online Access:	http://www.sciencedirect.com/science/article/pii/S2472630324001146